In the mouse model of AD with tau spreading, exogenous TFEB expression was extensively noted in astrocytes, which was capable of capturing and degrading tau, thus markedly alleviating tau-associated pathological alterations (Martini-Stoica et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.